Pepscan Peptides: Real Peptide-Technology Company vs Gray-Market Namesake

The original Pepscan is Pepscan Therapeutics (formerly known under the parent of Pepscan Presto), a Dutch biotech company specializing in constrained-peptide chemistry. Their foundational technology is the conformational epitope mapping method — overlapping constrained peptides synthesized on a planar surface to identify antibody-binding surfaces — and they have an established literature record in that field. Their peptide products include custom libraries, constrained-peptide reagents, and selected discovery-stage molecules. They are a research-supply vendor, not a gray-market vial retailer.

Differentiation from a gray-market namesake is straightforward. The real Pepscan operates a B2B sales channel rather than B2C vial storefronts; their paperwork is a Certificate of Analysis in a custom-research-supply format; their reference list includes named academic and pharma customers; they have been operating under the Pepscan name for decades. The where-to-buy pillar lists the real Pepscan as a research-supply tier entry, distinct from any same-name retailer.

Some research-vial retailers use the "Pepscan" or "pepscan-peptides" name without any operational link to the original Pepscan. The two operate under different business models (B2B custom research vs. B2C retail vial), different geographies (Netherlands-based headquarters vs. anonymous web storefronts), and different documentation paths (peer-reviewed publications and CDMO paperwork vs. lot-matched COAs on retail pages). The editorial policy of this site treats namesakes as separate suppliers.

The disambiguation is what matters for the buyer. A buyer searching "pepscan peptides" expecting the Dutch biotech's custom-supply channel will end up on a research-vial storefront if they use a generic search; a buyer searching for the peptide-technology company will land on the biotech's professional channel. The top-companies pillar lists both under their operating names and notes the overlap when it occurs.

Three patterns. (1) Buyers order a research-vial SKU expecting a custom-research order, and discover on receipt that the delivery is a single vial rather than the planned-synthesis custom product. (2) Buyers order a constrained-peptide library expecting a gray-market vial, and discover on receipt that the delivery is a synthesis report rather than a vial. (3) Buyers order from a gray-market namesake expecting CDMO-grade documentation, and receive a vendor-issued COA that does not match the standard the original Pepscan operates under.

All three patterns are reading-flow problems the where-to-buy pillar calls out explicitly. The fix is straightforward — check the seller's operating entity and operating name; use the original Pepscan's own channels (and pricing) for custom-research supplies, and use the research-vial tier's documented channels for retail vial purchases. The two are not competing suppliers; they are different supply tiers with the same name.

Is Pepscan still active? Yes — the Dutch biotech operates under Pepscan Therapeutics with a continuously updated scientific and product line. The original Pepscan Presto brand has been integrated into the parent structure.

Are their methods peer-reviewed? Yes — the conformational epitope mapping technology is described in the primary literature and is the foundation of the company's customer base.

Step 1 — place the offer in a tier. Before comparing prices around Pepscan Peptides, use the table above to classify whatever listing or quote you are looking at: documentation, price position, net-content disclosure, retest availability. Two offers in the same tier compare cleanly; two offers in different tiers mostly compare paperwork. Step 2 — normalize the price. Divide by milligrams of net peptide content, not fill weight, and check the result against the synthesis-cost floor. The surviving differences are real market signal — geography, service, and documentation premium. Step 3 — price the risk you can see. Irreversible payment channels, young domains, and absent retests are each worth a measurable discount before any offer is competitive. The tier framework and cost-floor arithmetic come from the where to buy peptides pillar; for a concrete adjacent case study see What Is Alpha Labs Peptides? Vendor-Type Explainer.

Every sourcing question in this cluster comes down to comparing the same handful of market parameters. This table normalizes them so any vendor or listing can be placed in its tier before any price is compared.

Table: Parameter comparison: the three sourcing tiers side by side — apply it to any page in this cluster.